AnaptysBio, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2026
Total Assets: $317.0M
Liabilities Breakdown FY2026
Total Liabilities: $306.4M
Asset Breakdown
Total Assets: $317.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $133.8M | 42.2% |
| Accounts Receivable | $25.6M | 8.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $102.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $157.4M | 49.7% |
Liabilities Breakdown
Total Liabilities: $306.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.4M | 1.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $302.0M | 98.6% |